General [[side effect]]s for rotigotine may include [[constipation]], [[dyskinesia]], [[nausea]], [[vomiting]], [[dizziness]], [[Fatigue (medical)|fatigue]], [[insomnia]], [[somnolence]], [[confusion]], and [[hallucination]]s.<ref name="pmid20082541">{{cite journal |vauthors=Kulisevsky J, Pagonabarraga J | title = Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trials | journal = Drug Safety | volume = 33 | issue = 2 | pages = 147–61 | year = 2010 | pmid = 20082541 | doi = 10.2165/11319860-000000000-00000 | url = http://content.wkhealth.com/linkback/openurl?issn=0114-5916&volume=33&issue=2&spage=147}}</ref><ref name="pmid14676046">{{cite journal | title = A controlled trial of rotigotine monotherapy in early Parkinson's disease | journal = Archives of Neurology | volume = 60 | issue = 12 | pages = 1721–8 |date=December 2003 | pmid = 14676046 | doi = 10.1001/archneur.60.12.1721 | url = http://archneur.ama-assn.org/cgi/pmidlookup?view=long&pmid=14676046}}</ref> More serious complications can include [[psychosis]] and [[impulse control disorder]]s like [[hypersexuality]], [[punding]], and [[pathological gambling]].<ref name="pmid18978496">{{cite journal |vauthors=Wingo TS, Evatt M, Scott B, Freeman A, Stacy M | title = Impulse control disorders arising in 3 patients treated with rotigotine | journal = Clinical Neuropharmacology | volume = 32 | issue = 2 | pages = 59–62 | year = 2009 | pmid = 18978496 | doi = 10.1097/WNF.0B013E3181684542 | url = http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0362-5664&volume=32&issue=2&spage=59}}</ref> Mild adverse skin reactions at the patch application site may also occur.<ref name="pmid19947805"/><ref name="pmid14676046"/>

 

